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Background: A 21-year-old female patient had chorioretinitis in the left eye which relapsed while being on
anti-tubercular treatment and oral corticosteroids leading to blindness and the loss of the left eye.
Findings: Mycobacterium tuberculosis causing chorioretinitis showed a poor response, and the lung lesions
showed a good response to the same anti-tubercular treatment.
Conclusions: Mycobacterium tubercle bacilli in the eye may show a poor response to the anti-tubercular drugs
due to poor ocular penetration of the drugs secondary to early ocular hypoxia.
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Introduction
Intraocular tuberculosis represents an extrapulmonary
form of tuberculosis. Posterior uveitis is the most com-
mon manifestation of intraocular tuberculosis [1]. The
inflammation predominantly involves the choroid in the
form of choroidal tubercles, tuberculoma, sub-retinal
abscess, chorioretinitis, and serpiginous-like choroiditis.
We report a case of pulmonary and intraocular tubercu-
losis which showed a good response to the anti-tubercular
drugs in the lungs but not in the eye leading to a blinding
posterior tubercular uveitis.Case report
A 21-year-old female presented with sudden painless
diminution of vision in the left eye for 10 days. There
was an associated history of low grade fever with even-
ing rise and nonpurulent cough. There was a history of
pulmonary tuberculosis in her brother. On examination,
the best corrected visual acuity (BCVA) was 20/20, N6
in the right eye and counting finger close to face in the
left eye. Slit lamp examination was unremarkable in both
eyes. Fundus examination of the right eye was normal,
and the left eye showed a granuloma on the optic nerve
head (ONH) with perivascular sheathing and chorioreti-
nitis patch with overlying retinal hemorrhages in the
macula (Figure 1).* Correspondence: agarwalmannii@yahoo.co.in
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in any medium, provided the original work is pBlood investigation showed hemoglobin 7.6 gm%, raised
erythrocyte sedimentation rate (ESR) 65 mm in the first
hour, and Mantoux test −26 × 26 mm. Sputum test was
negative for acid fast bacilli. Chest X-ray was normal and
a high-resolution computed tomography (HRCT)-thorax
scan showed enlarged mediastinal lymph nodes with
necrosis in the center and patches of infiltration in the left
apical region and right lower lobe. She was evaluated by
the pulmonologist and started on four-drug regimen of
anti-tubercular therapy (ATT) comprising of rifampicin
600 mg/day, ethambutol, pyrazinamide and isoniazid,
and systemic corticosteroids 1 mg/kg body weight.
Topical prednisolone 1% eye drops and atropine 1%
were also started. There was evidence of mild vitritis
after 1 week on treatment.
After 1 month follow-up, the BCVA of the left eye was
counting fingers at 2 meters and fundus examination
showed a decrease in the size of the chorioretinitis
patch in the macula with a decrease in the paerivascu-
litis and the granuloma on the ONH (Figure 2).
Two weeks later, she presented with severe pain in the
left eye. BCVA in the left eye was counting fingers at 2
meters and fundus examination of the left eye showed
appearance of new patches of chorioretinitis in the macula
between the ONH and previous patch of chorioretinitis
(Figure 3). Systemic evaluation and repeat HRCT-thorax
showed resolution of the chest infiltrates. The systemic
corticosteroids were increased to 1.5 mg/kg/body weight
and oral ofloxacin 400 mg twice daily was added to the
ongoing four-drug ATT.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Granuloma on the ONH with perivascular sheathing and
chorioretnitis patch with retinal hemorrhages in the macula.
Figure 3 Appearance of new patches of chorioretinitis in
the macula.
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in the left eye to perception of light with extensive neo-
vascularization of the iris (NVI), posterior synechiae for-
mation, and early lenticular changes. The intraocular
pressure (IOP) by Goldmann applanation tonometer was
28 mm of Hg. Ultrasound B-scan showed exudative retinal
detachment with evidence of choroidal thickening. She
was treated with off-label use of intravitreal injections of
bevacizumab (Avastin, Genentech, South San Francisco,
CA, USA). The left eye subsequently became a painful
blind eye which was digitally soft with a decreased axial
length on ultrasound B-scan.Figure 2 The chorioretinitis patch in the macula decreased with
a decrease in the granuloma on the disc and perivasculitis.Enucleation with ball implant was done for the left eye
after an informed consent. Gross histopathology of the
left eyeball showed total retinal detachment with choroidal
thickening. Microscopic examination of the sub-retinal
areas showed extensive caseation necrosis with intraretinal
inflammation and dense collections of lymphocytes and
plasma cells, choroidal inflammation with lymphocytic
cells, chronic inflammation of the ciliary body, and
inflammation of the scleral fibers (Figure 4a,b,c).
On microbiological examination, acid fast bacilli (AFB)
stain was negative for mycobacterium tubercle bacilli.
Grams’ stain was negative for fungal filaments. Polyme-
rase chain reaction (PCR) for mycobacterium tubercu-
losis was positive with both the primers IS6110 and
MPb 64 (Figure 5).
She was subsequently dispensed with a prosthetic shell
for the left socket.
Discussion
Tuberculosis is a clinical disease caused by infection
with Mycobacterium tuberculosis and is characterized
pathologically by the formation of granulomas [2]. It is
commonly described as a systemic disease of ‘protean
manifestations’ that mainly involves the lungs. Extra-
pulmonary involvement, including lesions of the gas-
trointestinal tract, genito-urinary tract, cardiovascular
system, skin, central nervous system, and eyes, may occur
either in association with clinically apparent pulmonary
tuberculosis or in isolation, with no clinical or laboratory
evidence of pulmonary infection. In India, where pulmo-
nary tuberculosis is endemic, the incidence of ocular
involvement is variable [3].
In our patient, there was initially a response to the oral
corticosteroids and four-drug ATT; however, this was
2 weeks later followed by a deterioration in the left eye
and improvement in the lung lesions while being on
treatment. We got different response in the lungs and in
the eye even though it is presumed that the strain of
Figure 4 Microscopic examination of the sub-retinal areas (a,b,c).
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lungs would also be the causative bacilli in the left eye.
This excludes the fact that our case was of a multidrug-
resistant tuberculosis as then neither lungs or the eye
would have responded to the treatment. There was a resis-
tance to start second line anti-tubercular drugs seeing toFigure 5 Positive polymerase chain reaction for mycobacterium tubethe resolution of the chest lesions; however, oral ofloxacin
was added which failed to provide any additional benefit.
We were unable to see the antibiotic sensitivity of the
mycobacterium tubercle bacilli as the microbiology testing
showed no growth though the polymerase chain reaction
confirmed the same.rculosis.
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essential that pulmonary and extrapulmonary manifestation
especially ocular involvement of tuberculosis may show the
same response to the ATT. This maybe secondary to the
fact that ocular hypoxia sets in very fast in eyes with inflam-
mation of the choroid secondary to mycobacterium tuber-
culosis [4-6]. This causes decreased choroidal circulation,
and this may reduce the penetration of the drugs of ATT
into the eye. Early neovascular complications are seen in
these eyes secondary to ocular hypoxia as in our case where
we treated our patient with multiple intravitreal injections
of bevacizumab (Avastin,Genentech) which is a non-
selective vascular endothelial growth factor inhibitor provi-
ding relief from pain till the eye was enucleated. We need to
be very careful and follow a case of intraocular tuberculosis
at frequent intervals as there maybe a very fast progression
of ocular tuberculosis leading to a complete loss of the eye.
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